Syneos Health Inc is a provider of integrated biopharmaceutical solutions. The company operates its business through two operating segments – Clinical Solutions and Commercial Solutions. Its Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics spanning Phase I to IV of clinical development. This segment covers clinical pharmacology and bioanalytical services, workforce deployment, clinical studies, real-world evidence, and consulting. It also offers individual services comprising product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs spanning a range of treatment areas. The company’s Commercial Solutions segment provides commercialization services such as deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services. Syneos Health’s early phase offerings consist of services for Phase I to Phase IIA clinical trial conduct, bioanalytical assay development and analysis, targeted translational science offerings, and clinical pharmacology services, including modelling and simulation. It also provides validation and sample analysis services such as pre-clinical development, post-marketing support, and purpose-built early-phase biometrics support. The company’s deployment solutions include field-based promotional and market access solutions, field-based clinical solutions, inside sales and contact centers, insight and strategy design, patient support services, training, talent sourcing, and end-to-end sales operations.